This report on nanobiotechnology market studies various technologies and application. Nanobiotechnology deals with biological and biochemical applications or applications. Nanobiotechnology mostly studies existing elements of living organisms and nature to fabricate new nano-devices. The potential uses and benefits of nanotechnology are vast. The major applications of nanobiotechnology exist in biomedical field and are primarily targeted towards development of novel drug delivery systems, and it is expected to remain the major application of nanobiotechnology throughout the forecast period.
For the purpose of this study, the global nanobiotechnology market on the basis of technology type is segmented into nanoparticles, nanocrystals, quantum dots, liposomes, polymer structures dendrimers, nanopores, and intergrated nanostructures. Market size estimates and forecast for these segments for the period 2020 to 2030 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2023 to 2030, considering 2021 as the base year.
On the basis of application type nanobiotechnology market is segmented as drug delivery, sequencing, biologic imaging, research tools and microbicide. Market size estimates and forecast for these segments for the period 2020 to 2030 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2023 to 2030, considering 2021 as the base year.
The nanobiotechnology market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2020 to 2030 and their CAGRs for the period 2023 to 2030 are provided in this report.
The major key players profiled in the nanobiotechnology market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The key players profiled in this report are Aduro BioTech, Calando Pharmaceuticals Inc., Baxter International, Inc., Fresinuns Kabi AG, Smith & Nephew plc, Biosante Phosphate Pharmaceuticals Inc., Celgene Corporation, Elan Pharmaceuticals Inc., Flamel Technologies Inc., Nanophase Technologies Corporation, Sigma Aldrich Company, Dendritic Nanotechnologies Inc. and SkyePharma Pharmaceuticals.
On the basis of application nanobiotechnology market is segmented into drug delivery, sequencing, biologic imaging, research tools and microbicide. In base year 2021, drug delivery and sequencing segments were observed as the largest segments of nanobiotechnology accounted for the market share of around 55%. Biotechnology and pharmaceutical industries are expected to remain the largest end-users of nanobiotechnology. Market experts suggested that drug delivery is the most crucial pharmaceutical application and now is the most focused area in nanobiotechnology. In drug delivery application apart from solving solubility issues of drug it also assists to enhance intracellular delivery possibilities and the level of skin permeability in transdermal drug delivery. Thus, nanobiotechnology possesses the potential to develop breakthrough interface systems that allows interaction between novel electronic devices and biological systems.
In base year 2021, the segments liposomes and polymer structure dendrimers collectively account for the major market share of around 50% and are expected to maintain market dominance throughout the forecast period. The rising prevalence of cancer, increasing public awareness related to novel treatments for cancer, and constant technological upgradation in the field of nanotechnology research and development. The major restrains of this market especially in emerging and underdeveloped economies are scarcity of resources and mounting technological cost. However, rising demand from pharmaceutical domain is expected to open up novel growth opportunities within the forecast period. Market experts suggest that nanobiotechnology also possess the capability to develop breakthrough interface systems between physical objects and living cells to allow interaction of modern electronic devices with biological systems. The decades of in-depth research and development in nanobiotechnology is now assisting access to novel avenues of healthcare such as synthesis of advanced nanofabricated systems and devices for treating several untreatable diseases.
In base year 2021, North America accounted for the largest share in the global nanobiotechnology market, followed by Europe, Asia-Pacific, LATAM and MEA. The Asia-Pacific region (comprising Japan, China and India as major countries) is anticipated to grow at the fastest CAGR during the forecast period 2023 - 2030. The key factors assisting the growth of nanobiotechnology market in North America and Europe are such as rising prevalence of cancer, high acceptance rate in case of novel mode of treatments, high accessibility to advanced healthcare infrastructure and favorable environment for nanobiotechnology–based research and development. Asia-Pacific was observed as the fastest growing region throughout the forecast period 2023 – 2030 due to rising public awareness related to cancer diagnosis and treatment, developing healthcare services and research and development infrastructure, and high market penetration and acceptance of novel treatment technologies. The major restrains of this market especially in emerging and underdeveloped economies are scarcity of resources and mounting technological cost. However, rising demand from pharmaceutical domain is expected to open up novel growth opportunities within the forecast period.
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Nanobiotechnology market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2022-2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Year | 2022 |
| Unit | USD Million |
| Segmentation | |
Technology Type
| |
Applications
| |
|
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report
